Geron shares surge 10.92% intraday as market forecasts $420B anti-aging therapies market by 2030, RYTELO gains FDA/EU approvals, and 2025 net revenue jumps 138.8% to $183.9M.
ByAinvest
Friday, Mar 6, 2026 10:34 am ET1min read
GERN--
Geron surged 10.92% intraday trading, driven by a market report projecting the global anti-aging therapies market to exceed $420 billion by 2030 with an 8-9% CAGR, highlighting GERN as a related biotech company. Additionally, RYTELO received FDA approval in 2024 for low-risk myelodysplastic syndrome and European Commission approval in 2025 for transfusion-dependent anemia, with 2025 net revenue reaching $183.9 million, a 138.8% year-over-year increase.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet